MIKE DAVIS: Foreign weight-loss drugmaker seeks fat profits by gobbling up American upstart Novo Nordisk attempts to acquire weight-loss drug company Metsera during government shutdown, potentially avoiding FTC antitrust review and regulatory scrutiny. Orignial Source: https://www.foxbusiness.com/fox-news-opinion/mike-davis-foreign-weight-loss-drugmaker-seeks-fat-profits-gobbling-up-american-upstart Previous article: Bessent says he's 'optimistic' as Supreme Court weighs fate of Trump's entire trade agenda Prev Next article: Return to office gaining momentum as AI reshapes corporate strategy Next
